Our Business Developer Jordan Palfrey is looking forward to attending the 3rd GPCR-Targeted Drug Discovery Summit in Boston from March 5-7, 2024. Please connect with Jordan if you’re interested in discovering GPCR therapeutic peptide hits using Orbit’s direct-to-cell high throughput functional screening capabilities. We’d be delighted to learn more and discuss how we can help!

Dr Jordan Palfry will be attending TIDES Europe between the 16th and 18th November. If you have an interest in peptide discovery, be it for targeting cells, PROTACS and molecular Glues or for functional screening in identifying GPCR agonists, please connect via info@orbitdiscovery.com. We look forward to meeting you  in Boulder